Evaluation, pilot, and repeat PCR lots serve different purposes. An evaluation lot asks whether a configured material fits the technical workflow. A pilot lot asks whether the defined manufacturing and packaging process can be executed at a representative scale. Repeat manufacturing applies the approved definition to planned supply cycles.
Evaluation lots answer technical questions
Evaluation material is intentionally limited and may be produced with more development flexibility than repeat supply. It can support comparison with the originating bench preparation, assessment of liquid or dry format, workflow handling, preliminary packaging review, and identification of variables that still need refinement.
Pilot lots test the intended process
Pilot work uses a more defined bill of materials, manufacturing instruction, fill configuration, packaging approach, and release plan. The quantity should be large enough to expose process realities without creating unnecessary inventory before the product definition is ready.
Repeat lots require a controlled definition
Repeat supply depends on approved material specifications, controlled suppliers, batch records, in-process checks, release criteria, packaging instructions, storage conditions, lot identification, records, and a process for reviewing changes. Forecast and lead time should be aligned with material availability and manufacturing capacity.
Do not use quantity as a substitute for readiness
Ordering more units does not make an assay more mature. Large quantities made before formulation, packaging, and acceptance criteria are stable can lock in an unsuitable design and create expensive investigation work.
Define the decision at every stage
Before each lot, write the questions it must answer, the material and data needed, who reviews results, and what decision follows. This keeps development, laboratory evaluation, and manufacturing evidence from being blended into one vague milestone.
Plan the handoff to routine ordering
The transition to repeat supply should document the approved configuration, expected order range, reorder point, shelf-life or storage basis available at that stage, retained samples where applicable, and the communication route for deviations or changes.